| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Biology, University of York, Heslington, York YO1 5DD, United Kingdom
2 To whom requests for reprints should be adressed, at Department of Biology, University of York, Heslington, York YO1 5DD, United Kingdom.
The p53 protein is a transcription factor, the function of which is abrogated by oncogenic mutations which affect a flexible domain in the central portion of p53, altering its reactivity with conformation-specific antibodies. Here we show that both conformation and sequence-specific DNA binding of p53 translated in vitro can be modulated by metal chelators and oxidizing agents. Oxidation disrupted wild-type p53 conformation and inhibited DNA binding. Conversely, reduction favored folding of p53 into the wild-type form and restored DNA binding. Redox regulation of p53 protein conformation could represent an important mechanism for the control of p53 function.
1 This work was supported by a Yorkshire Cancer Research Campaign program grant to J. M.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 7/12/93. Accepted 8/17/93.
This article has been cited by other articles:
![]() |
J. Zhao, J. Chen, B. Lu, L. Dong, H. Wang, C. Bi, G. Wu, H. Guo, M. Wu, and Y. Guo TIP30 Induces Apoptosis under Oxidative Stress through Stabilization of p53 Messenger RNA in Human Hepatocellular Carcinoma Cancer Res., June 1, 2008; 68(11): 4133 - 4141. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Augustyn, E. J. Merino, and J. K. Barton A role for DNA-mediated charge transport in regulating p53: Oxidation of the DNA-bound protein from a distance PNAS, November 27, 2007; 104(48): 18907 - 18912. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. V. Guijarro, J. F.M. Leal, C. Blanco-Aparicio, S. Alonso, J. Fominaya, M. Lleonart, J. Castellvi, S. Ramon y Cajal, and A. Carnero MAP17 enhances the malignant behavior of tumor cells through ROS increase Carcinogenesis, October 1, 2007; 28(10): 2096 - 2104. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Aichler, H. Algul, D. Behne, G. Holzlwimmer, B. Michalke, L. Quintanilla-Martinez, J. Schmidt, R. M. Schmid, and M. Brielmeier Selenium status alters tumour differentiation but not incidence or latency of pancreatic adenocarcinomas in Ela-TGF-{alpha} p53+/ mice Carcinogenesis, September 1, 2007; 28(9): 2002 - 2007. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Aschner, T. Syversen, D. O. Souza, and J. B.T. Rocha Metallothioneins: mercury species-specific induction and their potential role in attenuating neurotoxicity. Experimental Biology and Medicine, October 1, 2006; 231(9): 1468 - 1473. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. F. Vitiello, R. J. Staversky, S. C. Gehen, C. J. Johnston, J. N. Finkelstein, T. W. Wright, and M. A. O'Reilly p21Cip1 Protection against Hyperoxia Requires Bcl-XL and Is Uncoupled from Its Ability to Suppress Growth Am. J. Pathol., June 1, 2006; 168(6): 1838 - 1847. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Gong, H. Sohn, L. Xue, G. L. Firestone, and L. F. Bjeldanes 3,3'-Diindolylmethane Is a Novel Mitochondrial H+-ATP Synthase Inhibitor that Can Induce p21Cip1/Waf1 Expression by Induction of Oxidative Stress in Human Breast Cancer Cells. Cancer Res., May 1, 2006; 66(9): 4880 - 4887. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Panduri, S. Surapureddi, S. Soberanes, S. A. Weitzman, N. Chandel, and D. W. Kamp P53 Mediates Amosite Asbestos-Induced Alveolar Epithelial Cell Mitochondria-Regulated Apoptosis Am. J. Respir. Cell Mol. Biol., April 1, 2006; 34(4): 443 - 452. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. Pinto, B. F. Krasnikov, and A. J. L. Cooper Redox-Sensitive Proteins Are Potential Targets of Garlic-Derived Mercaptocysteine Derivatives J. Nutr., March 1, 2006; 136(3): 835S - 841S. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Esser, M. Scheffner, and J. Hohfeld The Chaperone-associated Ubiquitin Ligase CHIP Is Able to Target p53 for Proteasomal Degradation J. Biol. Chem., July 22, 2005; 280(29): 27443 - 27448. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Fang, J. Lu, and A. Holmgren Thioredoxin Reductase Is Irreversibly Modified by Curcumin: A NOVEL MOLECULAR MECHANISM FOR ITS ANTICANCER ACTIVITY J. Biol. Chem., July 1, 2005; 280(26): 25284 - 25290. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Nalvarte, A. E. Damdimopoulos, C. Nystom, T. Nordman, A. Miranda-Vizuete, J. M. Olsson, L. Eriksson, M. Bjornstedt, E. S. J. Arner, and G. Spyrou Overexpression of Enzymatically Active Human Cytosolic and Mitochondrial Thioredoxin Reductase in HEK-293 Cells: EFFECT ON CELL GROWTH AND DIFFERENTIATION J. Biol. Chem., December 24, 2004; 279(52): 54510 - 54517. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. G. McLure, M. Takagi, and M. B. Kastan NAD+ Modulates p53 DNA Binding Specificity and Function Mol. Cell. Biol., November 15, 2004; 24(22): 9958 - 9967. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Damdimopoulos, A. Miranda-Vizuete, E. Treuter, J.-A. Gustafsson, and G. Spyrou An Alternative Splicing Variant of the Selenoprotein Thioredoxin Reductase Is a Modulator of Estrogen Signaling J. Biol. Chem., September 10, 2004; 279(37): 38721 - 38729. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Conour, W. V. Graham, and H. R. Gaskins A combined in vitro/bioinformatic investigation of redox regulatory mechanisms governing cell cycle progression Physiol Genomics, July 8, 2004; 18(2): 196 - 205. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Cobbs, T. R. Whisenhunt, D. R. Wesemann, L. E. Harkins, E. G. Van Meir, and M. Samanta Inactivation of Wild-Type p53 Protein Function by Reactive Oxygen and Nitrogen Species in Malignant Glioma Cells Cancer Res., December 15, 2003; 63(24): 8670 - 8673. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Wittke, R. Wiedemeyer, A. Pillmann, L. Savelyeva, F. Westermann, and M. Schwab Neuroblastoma-Derived Sulfhydryl Oxidase, a New Member of the Sulfhydryl Oxidase/Quiescin6 Family, Regulates Sensitization to Interferon {gamma}-Induced Cell Death in Human Neuroblastoma Cells Cancer Res., November 15, 2003; 63(22): 7742 - 7752. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Imazawa, A. Nishikawa, K. Toyoda, F. Furukawa, M. Mitsui, and M. Hirose Sequential Alteration of Apoptosis, p53 Expression, and Cell Proliferation in the Rat Pancreas Treated with 4-Hydroxyaminoquinoline 1-Oxide Toxicol Pathol, October 1, 2003; 31(6): 625 - 631. [Abstract] [PDF] |
||||
![]() |
S.X. Liang and D.R. Richardson The effect of potent iron chelators on the regulation of p53: examination of the expression, localization and DNA-binding activity of p53 and the transactivation of WAF1 Carcinogenesis, October 1, 2003; 24(10): 1601 - 1614. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Biswal, T. Maxwell, T. Rangasamy, and J. P. Kehrer Modulation of benzo[a]pyrene-induced p53 DNA activity by acrolein Carcinogenesis, August 1, 2003; 24(8): 1401 - 1406. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Brash and P. A. Havre New careers for antioxidants PNAS, October 29, 2002; 99(22): 13969 - 13971. [Full Text] [PDF] |
||||
![]() |
K. B. Ewan, R. L. Henshall-Powell, S. A. Ravani, M. J. Pajares, C. Arteaga, R. Warters, R. J. Akhurst, and M. H. Barcellos-Hoff Transforming Growth Factor-{beta}1 Mediates Cellular Response to DNA Damage in Situ Cancer Res., October 15, 2002; 62(20): 5627 - 5631. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.R. Merwin, D.J. Mustacich, E.G.D. Muller, G.D. Pearson, and G.F. Merrill Reporter gene transactivation by human p53 is inhibited in thioredoxin reductase null yeast by a mechanism associated with thioredoxin oxidation and independent of changes in the redox state of glutathione Carcinogenesis, October 1, 2002; 23(10): 1609 - 1616. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Yang, R. Zhang, X. W. Wang, E. A. Spillare, S. P. Linke, D. Subramanian, J. D. Griffith, J. L. Li, I. D. Hickson, J. C. Shen, et al. The Processing of Holliday Junctions by BLM and WRN Helicases Is Regulated by p53 J. Biol. Chem., August 23, 2002; 277(35): 31980 - 31987. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Ma, J. Hu, D. J. Lindner, and D. V. Kalvakolanu Mutational Analysis of Human Thioredoxin Reductase 1. EFFECTS ON p53-MEDIATED GENE EXPRESSION AND INTERFERON AND RETINOIC ACID-INDUCED CELL DEATH J. Biol. Chem., June 14, 2002; 277(25): 22460 - 22468. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Buzek, L. Latonen, S. Kurki, K. Peltonen, and M. Laiho Redox state of tumor suppressor p53 regulates its sequence-specific DNA binding in DNA-damaged cells by cysteine 277 Nucleic Acids Res., June 1, 2002; 30(11): 2340 - 2348. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. T. Morgan, Hong Ni, H. R. Brown, L. Yoon, C. W. Qualls JR, L. M. Crosby, R. Reynolds, B. Gaskill, S. P. Anderson, T. B. Kepler, et al. Application of cDNA Microarray Technology to In Vitro Toxicology and the Selection of Genes for a Real-Time RT-PCR-Based Screen for Oxidative Stress in Hep-G2 Cells Toxicol Pathol, June 1, 2002; 30(4): 435 - 451. [Abstract] [PDF] |
||||
![]() |
G. Ferbeyre, E. de Stanchina, A. W. Lin, E. Querido, M. E. McCurrach, G. J. Hannon, and S. W. Lowe Oncogenic ras and p53 Cooperate To Induce Cellular Senescence Mol. Cell. Biol., May 15, 2002; 22(10): 3497 - 3508. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Havre, S. O'Reilly, J. J. McCormick, and D. E. Brash Transformed and Tumor-derived Human Cells Exhibit Preferential Sensitivity to the Thiol Antioxidants, N-Acetyl Cysteine and Penicillamine Cancer Res., March 1, 2002; 62(5): 1443 - 1449. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Uberti, T. Carsana, E. Bernardi, L. Rodella, P. Grigolato, C. Lanni, M. Racchi, S. Govoni, and M. Memo Selective impairment of p53-mediated cell death in fibroblasts from sporadic Alzheimer's disease patients J. Cell Sci., January 8, 2002; 115(15): 3131 - 3138. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Zhong and T. D. Oberley Redox-mediated Effects of Selenium on Apoptosis and Cell Cycle in the LNCaP Human Prostate Cancer Cell Line Cancer Res., October 1, 2001; 61(19): 7071 - 7078. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Abeysinghe, B. T. Greene, R. Haynes, M. C. Willingham, J. Turner, R. P. Planalp, M.W. Brechbiel, F. M. Torti, and S. V. Torti p53-independent apoptosis mediated by tachpyridine, an anti-cancer iron chelator Carcinogenesis, October 1, 2001; 22(10): 1607 - 1614. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hanausek, P. Ganesh, Z. Walaszek, C. J. Arntzen, T. J. Slaga, and J. U. Gutterman From the Cover: Avicins, a family of triterpenoid saponins from Acacia victoriae (Bentham), suppress H-ras mutations and aneuploidy in a murine skin carcinogenesis model PNAS, September 25, 2001; 98(20): 11551 - 11556. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. O'Reilly DNA damage and cell cycle checkpoints in hyperoxic lung injury: braking to facilitate repair Am J Physiol Lung Cell Mol Physiol, August 1, 2001; 281(2): L291 - L305. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Liu, H. Asch, and M. F. Kulesz-Martin Functional Quantification of DNA-binding Proteins p53 and Estrogen Receptor in Cells and Tumor Tissues by DNA Affinity Immunoblotting Cancer Res., July 1, 2001; 61(14): 5402 - 5406. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Liu and M. Kulesz-Martin p53 protein at the hub of cellular DNA damage response pathways through sequence-specific and non-sequence-specific DNA binding Carcinogenesis, June 1, 2001; 22(6): 851 - 860. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Shen, Z. J. Chen, J. T. Zilfou, E. Hopper, M. Murphy, and K. D. Tew Binding of the Aminothiol WR-1065 to Transcription Factors Influences Cellular Response to Anticancer Drugs J. Pharmacol. Exp. Ther., June 1, 2001; 297(3): 1067 - 1073. [Abstract] [Full Text] |
||||
![]() |
H. E. MARSHALL, K. MERCHANT, and J. S. STAMLER Nitrosation and oxidation in the regulation of gene expression FASEB J, October 1, 2000; 14(13): 1889 - 1900. [Abstract] [Full Text] |
||||
![]() |
J. P. Kehrer and S. S. Biswal The Molecular Effects of Acrolein Toxicol. Sci., September 1, 2000; 57(1): 6 - 15. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Wang, S. S. Leonard, J. Ye, M. Ding, and X. Shi The role of hydroxyl radical as a messenger in Cr(VI)-induced p53 activation Am J Physiol Cell Physiol, September 1, 2000; 279(3): C868 - C875. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Reaves, J. C. Fanzo, K. Arima, J. Y. J. Wu, Y. R. Wang, and K. Y. Lei Expression of the p53 Tumor Suppressor Gene Is Up-Regulated by Depletion of Intracellular Zinc in HepG2 Cells J. Nutr., July 1, 2000; 130(7): 1688 - 1694. [Abstract] [Full Text] |
||||
![]() |
D. L. Cheo, L. B. Meira, D. K. Burns, A. M. Reis, T. Issac, and E. C. Friedberg Ultraviolet B Radiation-induced Skin Cancer in Mice Defective in the Xpc, Trp53, and Apex (HAP1) Genes: Genotype-specific Effects on Cancer Predisposition and Pathology of Tumors Cancer Res., March 1, 2000; 60(6): 1580 - 1584. [Abstract] [Full Text] |
||||
![]() |
V. Arora and P. L. Iversen Antisense Oligonucleotides Targeted to the p53 Gene Modulate Liver Regeneration In Vivo Drug Metab. Dispos., February 1, 2000; 28(2): 131 - 138. [Abstract] [Full Text] |
||||
![]() |
G. WAHL and O. VAFA Genetic Instability, Oncogenes, and the p53 Pathway Cold Spring Harb Symp Quant Biol, January 1, 2000; 65(0): 511 - 520. [Abstract] [PDF] |
||||
![]() |
M. Ueno, H. Masutani, R. J. Arai, A. Yamauchi, K. Hirota, T. Sakai, T. Inamoto, Y. Yamaoka, J. Yodoi, and T. Nikaido Thioredoxin-dependent Redox Regulation of p53-mediated p21 Activation J. Biol. Chem., December 10, 1999; 274(50): 35809 - 35815. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Meplan, K. Mann, and P. Hainaut Cadmium Induces Conformational Modifications of Wild-type p53 and Suppresses p53 Response to DNA Damage in Cultured Cells J. Biol. Chem., October 29, 1999; 274(44): 31663 - 31670. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Fojta Effect of p53 Protein Redox States on Binding to Supercoiled and Linear DNA J. Biol. Chem., September 3, 1999; 274(36): 25749 - 25755. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kumar and A. Holmgren Induction of thioredoxin, thioredoxin reductase and glutaredoxin activity in mouse skin by TPA, a calcium ionophore and other tumor promoters Carcinogenesis, September 1, 1999; 20(9): 1761 - 1767. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. F. Merrill, P. Dowell, and G. D. Pearson The Human p53 Negative Regulatory Domain Mediates Inhibition of Reporter Gene Transactivation in Yeast Lacking Thioredoxin Reductase Cancer Res., July 1, 1999; 59(13): 3175 - 3179. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. W Kamp and S. A Weitzman The molecular basis of asbestos induced lung injury Thorax, July 1, 1999; 54(7): 638 - 652. [Full Text] |
||||
![]() |
M. Thomas, A. Kalita, S. Labrecque, D. Pim, L. Banks, and G. Matlashewski Two Polymorphic Variants of Wild-Type p53 Differ Biochemically and Biologically Mol. Cell. Biol., February 1, 1999; 19(2): 1092 - 1100. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. C. Lee, A. J. Crowe, and M. C. Barton p53-Mediated Repression of Alpha-Fetoprotein Gene Expression by Specific DNA Binding Mol. Cell. Biol., February 1, 1999; 19(2): 1279 - 1288. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Giaccia and M. B. Kastan The complexity of p53 modulation: emerging patterns from divergent signals Genes & Dev., October 1, 1998; 12(19): 2973 - 2983. [Full Text] |
||||
![]() |
G. Tell, A. Scaloni, L. Pellizzari, S. Formisano, C. Pucillo, and G. Damante Redox Potential Controls the Structure and DNA Binding Activity of the Paired Domain J. Biol. Chem., September 25, 1998; 273(39): 25062 - 25072. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Dudenhöffer, G. Rohaly, K. Will, W. Deppert, and L. Wiesmüller Specific Mismatch Recognition in Heteroduplex Intermediates by p53 Suggests a Role in Fidelity Control of Homologous Recombination Mol. Cell. Biol., September 1, 1998; 18(9): 5332 - 5342. [Abstract] [Full Text] |
||||
![]() |
H.-H. Wu and J. Momand Pyrrolidine Dithiocarbamate Prevents p53 Activation and Promotes p53 Cysteine Residue Oxidation J. Biol. Chem., July 24, 1998; 273(30): 18898 - 18905. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. O'Reilly, R. J. Staversky, B. R. Stripp, and J. N. Finkelstein Exposure to Hyperoxia Induces p53 Expression in Mouse Lung Epithelium Am. J. Respir. Cell Mol. Biol., January 1, 1998; 18(1): 43 - 50. [Abstract] [Full Text] |
||||
![]() |
A. Ritchie, A. Gotoh, J. Gaddy, S. E. Braun, and H. E. Broxmeyer Thrombopoietin Upregulates the Promoter Conformation of p53 in a Proliferation-Independent Manner Coincident With a Decreased Expression of Bax: Potential Mechanisms for Survival Enhancing Effects Blood, December 1, 1997; 90(11): 4394 - 4402. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Poluha, C. M. Schonhoff, K. S. Harrington, M. B. Lachyankar, N. E. Crosbie, D. A. Bulseco, and A. H. Ross A Novel, Nerve Growth Factor-activated Pathway Involving Nitric Oxide, p53, and p21WAF1 Regulates Neuronal Differentiation of PC12 Cells J. Biol. Chem., September 19, 1997; 272(38): 24002 - 24007. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Halleck, H. Liu, J. North, and J. L. Stevens Reduction of trans-4,5-Dihydroxy-1,2-dithiane by Cellular Oxidoreductases Activates gadd153/chop and grp78 Transcription and Induces Cellular Tolerance in Kidney Epithelial Cells J. Biol. Chem., August 29, 1997; 272(35): 21760 - 21766. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Fourie, T. R. Hupp, D. P. Lane, B.-C. Sang, M. S. Barbosa, J. F. Sambrook, and M.-J. H. Gething HSP70 Binding Sites in the Tumor Suppressor Protein p53 J. Biol. Chem., August 1, 1997; 272(31): 19471 - 19479. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Akamatsu, T. Ohno, K. Hirota, H. Kagoshima, J. Yodoi, and K. Shigesada Redox Regulation of the DNA Binding Activity in Transcription Factor PEBP2. THE ROLES OF TWO CONSERVED CYSTEINE RESIDUES J. Biol. Chem., June 6, 1997; 272(23): 14497 - 14500. [Abstract] [Full Text] [PDF] |
||||
![]() |
L Jayaraman, K G Murthy, C Zhu, T Curran, S Xanthoudakis, and C Prives Identification of redox/repair protein Ref-1 as a potent activator of p53. Genes & Dev., March 1, 1997; 11(5): 558 - 570. [Abstract] [PDF] |
||||
![]() |
A. G. Ostermeyer, E. Runko, B. Winkfield, B. Ahn, and U. M. Moll Cytoplasmically sequestered wild-type p53 protein in neuroblastoma is relocated to the nucleus by a C-terminal peptide PNAS, December 24, 1996; 93(26): 15190 - 15194. [Abstract] [Full Text] [PDF] |
||||
![]() |
L J Ko and C Prives p53: puzzle and paradigm. Genes & Dev., May 1, 1996; 10(9): 1054 - 1072. [PDF] |
||||
![]() |
T. Russo, N. Zambrano, F. Esposito, R. Ammendola, F. Cimino, M. Fiscella, J. Jackman, P. M. O'Connor, C. W. Anderson, and E. Appella A p53-independent Pathway for Activation of WAF1/CIP1 Expression Following Oxidative Stress J. Biol. Chem., December 8, 1995; 270(49): 29386 - 29391. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. R. Hupp and D. P. Lane Two Distinct Signaling Pathways Activate the Latent DNA Binding Function of p53 in a Casein Kinase II-independent Manner J. Biol. Chem., July 28, 1995; 270(30): 18165 - 18174. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Lazo, Y. Kondo, D. Dellapiazza, A. E. Michalska, K. H. A. Choo, and B. R. Pitt Enhanced Sensitivity to Oxidative Stress in Cultured Embryonic Cells from Transgenic Mice Deficient in Metallothionein I and II Genes J. Biol. Chem., March 10, 1995; 270(10): 5506 - 5510. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Di Leonardo, S.P. Linke, Y. Yin, and G.M. Wahl Cell Cycle Regulation of Gene Amplification Cold Spring Harb Symp Quant Biol, January 1, 1993; 58(0): 655 - 667. [Abstract] [PDF] |
||||
![]() |
R. S. Arnold, J. Shi, E. Murad, A. M. Whalen, C. Q. Sun, R. Polavarapu, S. Parthasarathy, J. A. Petros, and J. D. Lambeth Hydrogen peroxide mediates the cell growth and transformation caused by the mitogenic oxidase Nox1 PNAS, May 8, 2001; 98(10): 5550 - 5555. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Moos, K. Edes, and F. A. Fitzpatrick Inactivation of wild-type p53 tumor suppressor by electrophilic prostaglandins PNAS, August 1, 2000; 97(16): 9215 - 9220. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |